Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities
Kosuke Okazaki, Manabu Makinodan, Kazuhiko Yamamuro, Tomoyo Takata, Toshifumi Kishimoto Department of Psychiatry, Nara Medical University School of Medicine, Kashihara, JapanObjective: Methamphetamine (MA) use has recently been associated with high levels of psychiatric hospitalization and serious s...
Guardado en:
Autores principales: | Okazaki K, Makinodan M, Yamamuro K, Takata T, Kishimoto T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ef891a952396438a8f6f9cb5c5412e2b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Age of Onset and Its Related Factors in Cocaine or Methamphetamine Use in Adults from the United States: Results from NHANES 2005–2018
por: Alexandre Arthur Guerin, et al.
Publicado: (2021) -
Effects of Buprenorphine on the Memory and Learning Deficit Induced by Methamphetamine Administration in Male Rats
por: Farshid Etaee, et al.
Publicado: (2021) -
A Zebrafish Model of Neurotoxicity by Binge-Like Methamphetamine Exposure
por: Juliette Bedrossiantz, et al.
Publicado: (2021) -
FREQUENCY OF PSYCHOTIC SYMPTOMS IN METHAMPHETAMINE USERS
por: Ihsan Ullah Kasi, et al.
Publicado: (2020) -
Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence
por: Huan Liu, et al.
Publicado: (2021)